Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vascular endothelial growth factor A gene promoter is a DNA sequence upstream of the VEGFA gene that regulates its transcription. This promoter contains binding sites for multiple transcription factors, including hypoxia-inducible factor 1 alpha (HIF-1α), and is sensitive to both physiological and pathological stimuli such as hypoxia, inflammation, and oncogenic signaling. Genetic polymorphisms in the promoter can affect the levels of VEGFA expression, influencing susceptibility or progression of diseases that depend on angiogenesis, including cancer and vascular disorders. The promoter is not itself a therapeutic target, but its activity underlies the pathophysiologic relevance and druggability of the VEGFA signaling axis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular endothelial growth factor A gene promoter.